# Post Market Clinical Follow-Up Study - Medical Device KalobaGOLA ( PMCF )

> **NCT05985837** · — · COMPLETED · sponsor: **Schwabe Pharma Italia** · enrollment: 120 (actual)

## Conditions studied

- Sore-throat
- Pharyngitis

## Interventions

- **DEVICE:** KalobaGOLA spray (1)
- **DEVICE:** KalobaGOLA spray (2)
- **DEVICE:** KalobaGOLA tablets

## Key facts

- **NCT ID:** NCT05985837
- **Lead sponsor:** Schwabe Pharma Italia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-02
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05985837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05985837, "Post Market Clinical Follow-Up Study - Medical Device KalobaGOLA ( PMCF )". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05985837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*